Home
About
Overview
Sharing Data
ORCID
Help
History (31)
Virus Assembly
Hepatitis, Chronic
Psychosocial Deprivation
Patient Perceptions Impact Progression to Third-Line Therapy for Treatment of Overactive Bladder.
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
See All 31 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. Sci Adv. 2016 06; 2(6):e1501924.
View in:
PubMed
subject areas
Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Binding Sites
Breast Neoplasms
Chromatin
Cluster Analysis
Enhancer Elements, Genetic
Gene Expression Profiling
Genes, BRCA1
Genome-Wide Association Study
Genomics
Humans
Molecular Targeted Therapy
Nucleosomes
Nucleotide Motifs
Phenotype
Progestins
Prognosis
Protein Binding
Receptors, Estrogen
Receptors, Progesterone
Selective Estrogen Receptor Modulators
Signal Transduction
Tamoxifen
Treatment Outcome
authors with profiles
Geoffrey Greene